Law Offices of Howard G. Smith announces an investigation of potential claims against the board of directors of Amyris, Inc. (“Amyris” or the “Company) (NASDAQ: AMRS) concerning whether the board breached its fiduciary duties to shareholders.
On March 19, 2019, the Company announced it was unable to file its annual report for fiscal year ending December 31, 2018 on time, due to “the significant time and resources that were devoted to the accounting for and disclosure of the significant transactions with Koninklijke DSM N.V. that closed in November 2018.” Amyris also disclosed that it was “in the process of completing its evaluation of internal control over financial reporting.”
On this news, Amyris’s share price fell $0.78, or nearly 20% to close at $3.10 per share on March 20, 2019, thereby injuring investors.
Our investigation concerns whether the Company’s board of directors breached its fiduciary duties to shareholders and/or grossly mismanaged the Company in connection with the above alleged misconduct.
If you still hold Amyris shares purchased before March 2018, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201026005180/en/